Chargement en cours...
Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma
Gastric adenocarcinoma most often presents at an advanced stage and overall five-year survival of ~30%. Pharmacological ascorbate (high-dose IV ascorbate) has been proposed as a promising nontoxic adjuvant to standard radio-chemotherapies in several cancer types. In the current study, pharmacologica...
Enregistré dans:
| Publié dans: | Radiat Res |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6117840/ https://ncbi.nlm.nih.gov/pubmed/29547353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR14978.1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|